4//SEC Filing
Jackman Stephan 4
Accession 0001214659-22-011325
CIK 0001677077other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:30 PM ET
Size
5.0 KB
Accession
0001214659-22-011325
Insider Transaction Report
Form 4
Jackman Stephan
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-09-19$1.23/sh+8,500$10,414→ 8,500 total
Footnotes (1)
- [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.2252. The range of purchase prices on the transaction date was $1.225 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Documents
Issuer
Alzamend Neuro, Inc.
CIK 0001677077
Entity typeother
Related Parties
1- filerCIK 0001864257
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 4:30 PM ET
- Size
- 5.0 KB